Phibro Animal Health (PAHC) chair disposes 2,303 shares to cover tax withholding

Rhea-AI Filing Summary

PHIBRO ANIMAL HEALTH CORP Executive Chairman and 10% owner Jack Bendheim reported the disposition of 2,303 shares of Class A Common Stock on August 4, 2026. According to the disclosure, these shares were sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the vesting and settlement of restricted stock units. Following this transaction, Bendheim directly holds 14,537 Class A shares, and an affiliated entity, BFI Co., LLC, holds 56,152 shares over which he exercises voting and dispositive power while disclaiming beneficial ownership except for his pecuniary interest.

Insider Trade Summary

Net Seller: 2,303 shares

Net Sell 2 txns

Insider BENDHEIM JACK, BFI Co., LLC

Role Executive Chairman | 10% Owner

Type	Security	Shares	Price	Value
Other	Class A Common Stock F1, F2	2,303	$36.599	$84K
holding	Class A Common Stock F3	--	--	--

Holdings After Transaction: Class A Common Stock — 14,537 shares (Direct); Class A Common Stock — 56,152 shares (Indirect, See)

Footnotes (3)

1. F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
2. F2. The reported securities are directly held by Jack Bendheim.
3. F3. The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Key Figures

Shares disposed: 2,303 shares Transaction price: $36.599 per share Direct holdings after transaction: 14,537 shares +1 more

4 metrics

Shares disposed 2,303 shares Class A Common Stock disposition on August 4, 2026

Transaction price $36.599 per share Price for 2,303 Class A shares in cashless exercise

Direct holdings after transaction 14,537 shares Jack Bendheim’s direct Class A ownership post-transaction

Indirect holdings via BFI Co., LLC 56,152 shares Shares held by BFI Co., LLC over which Bendheim has voting and dispositive power

Key Terms

broker assisted cashless exercise program, restricted stock units, voting and dispositive power, disclaims beneficial ownership

4 terms

broker assisted cashless exercise program financial

"Represents shares sold in a broker assisted cashless exercise program to satisfy tax"

restricted stock units financial

"upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

voting and dispositive power financial

"exercises voting and dispositive power over BFI and may be deemed to have shared"

disclaims beneficial ownership regulatory

"Mr. Bendheim disclaims beneficial ownership of these securities except to the extent"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 08:12 PM Accepted by SEC EDGAR 08/06/2026 - 08:12 PM Learn about SEC filing dates

FAQ

What insider transaction did PAHC Executive Chairman Jack Bendheim report?

Jack Bendheim reported the disposition of 2,303 Class A shares of Phibro Animal Health on August 4, 2026, through a broker assisted cashless exercise to cover tax withholding on vested restricted stock units.

At what price were the 2,303 PAHC shares transacted by Jack Bendheim?

The 2,303 Class A shares were sold at an average price of $36.599 per share in a broker assisted cashless exercise program, used specifically to satisfy tax withholding obligations tied to vested restricted stock units.

How many PAHC shares does Jack Bendheim hold directly after this Form 4?

After the reported transaction, Jack Bendheim directly holds 14,537 shares of Phibro Animal Health Class A Common Stock, as reflected in the post-transaction ownership figure in the insider disclosure.

What is BFI Co., LLC’s relationship to PAHC shares in this filing?

BFI Co., LLC directly holds 56,152 PAHC shares. Jack Bendheim exercises voting and dispositive power over BFI and may be deemed to share voting and investment power but disclaims beneficial ownership beyond his pecuniary interest.

Was Jack Bendheim’s PAHC share transaction a discretionary sale?

The 2,303-share disposition was described as shares sold in a broker assisted cashless exercise to satisfy tax withholding on vested restricted stock units, indicating a tax-related transaction rather than a purely discretionary open-market sale.

How significant is the reported PAHC transaction relative to Jack Bendheim’s holdings?

The transaction involved 2,303 shares, compared with post-transaction holdings of 14,537 direct shares and 56,152 indirectly held through BFI Co., LLC, suggesting it represents a small portion of his overall reported equity exposure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BENDHEIM JACK

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/04/2026		J		2,303(1)	D	$36.599	14,537	D(2)
Class A Common Stock								56,152	I	See(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BENDHEIM JACK

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

1. Name and Address of Reporting Person^*

BFI Co., LLC

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.

2. The reported securities are directly held by Jack Bendheim.

3. The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

	/s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim	08/06/2026
	/s/ Judith Weinstein, as Attorney-in-Fact for BFI Co., LLC	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)